Relationship between the Size of Magnetic Nanoparticles and Efficiency of MRT Imaging of Cerebral Glioma in Rats
- Authors: Semkina A.S.1, Abakumov M.A.1, Abakumov A.M.2, Nukolova N.V.3, Chekhonin V.P.1,3
- 
							Affiliations: 
							- Department of Medical Nanobiotechnologies, Medical Biological Faculty, N. I. Pirogov Russian National Research Medical University
- Electron Microscopy for Materials Science (EMAT), University of Antwerp
- V. P. Serbsky Federal Medical Research Center of Psychiatry and Narcology, the Ministry of Health of the Russian Federation
 
- Issue: Vol 161, No 2 (2016)
- Pages: 292-295
- Section: Biotechnologies
- URL: https://journals.rcsi.science/0007-4888/article/view/237346
- DOI: https://doi.org/10.1007/s10517-016-3398-y
- ID: 237346
Cite item
Abstract
BSA-coated Fe3O4 nanoparticles with different hydrodynamic diameters (36±4 and 85±10 nm) were synthesized, zeta potential and T2 relaxivity were determined, and their morphology was studied by transmission electron microscopy. Studies on rats with experimental glioma C6 showed that smaller nanoparticles more effectively accumulated in the tumor and circulated longer in brain vessels. Optimization of the hydrodynamic diameter improves the efficiency of MRT contrast agent.
About the authors
A. S. Semkina
Department of Medical Nanobiotechnologies, Medical Biological Faculty, N. I. Pirogov Russian National Research Medical University
							Author for correspondence.
							Email: alevtina.semkina@gmail.com
				                					                																			                												                	Russian Federation, 							Moscow						
M. A. Abakumov
Department of Medical Nanobiotechnologies, Medical Biological Faculty, N. I. Pirogov Russian National Research Medical University
														Email: alevtina.semkina@gmail.com
				                					                																			                												                	Russian Federation, 							Moscow						
A. M. Abakumov
Electron Microscopy for Materials Science (EMAT), University of Antwerp
														Email: alevtina.semkina@gmail.com
				                					                																			                												                	Belgium, 							Groenenborgerlaan, Antwerp						
N. V. Nukolova
V. P. Serbsky Federal Medical Research Center of Psychiatry and Narcology, the Ministry of Health of the Russian Federation
														Email: alevtina.semkina@gmail.com
				                					                																			                												                	Russian Federation, 							Moscow						
V. P. Chekhonin
Department of Medical Nanobiotechnologies, Medical Biological Faculty, N. I. Pirogov Russian National Research Medical University; V. P. Serbsky Federal Medical Research Center of Psychiatry and Narcology, the Ministry of Health of the Russian Federation
														Email: alevtina.semkina@gmail.com
				                					                																			                												                	Russian Federation, 							Moscow; Moscow						
Supplementary files
 
				
			 
					 
						 
						 
						 
						 
				 
  
  
  
  
  Email this article
			Email this article  Open Access
		                                Open Access Access granted
						Access granted Subscription Access
		                                		                                        Subscription Access
		                                					